Leukemia/Lymphoma

Chronic Lymphocytic Leukemia/Small Cell Lymphoma:

IRB #H-39342/ DFCI #18-089: A Phase I/II Study of Duvelisib and Venetoclax in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Patients with Richter’s Syndrome